Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $21.2 million.

  • Journey Medical's Accumulated Expenses rose 3239.01% to $21.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.2 million, marking a year-over-year increase of 3239.01%. This contributed to the annual value of $17.4 million for FY2024, which is 1437.35% down from last year.
  • According to the latest figures from Q3 2025, Journey Medical's Accumulated Expenses is $21.2 million, which was up 3239.01% from $22.6 million recorded in Q2 2025.
  • Journey Medical's Accumulated Expenses' 5-year high stood at $26.0 million during Q3 2021, with a 5-year trough of $16.0 million in Q2 2024.
  • Its 5-year average for Accumulated Expenses is $20.3 million, with a median of $20.0 million in 2024.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first crashed by 3287.62% in 2023, then soared by 4120.96% in 2025.
  • Quarter analysis of 5 years shows Journey Medical's Accumulated Expenses stood at $22.7 million in 2021, then dropped by 14.71% to $19.4 million in 2022, then increased by 4.96% to $20.3 million in 2023, then dropped by 14.37% to $17.4 million in 2024, then rose by 21.62% to $21.2 million in 2025.
  • Its last three reported values are $21.2 million in Q3 2025, $22.6 million for Q2 2025, and $23.0 million during Q1 2025.